Navigation Links
New Poll Shows Public Worried About Medicare Cuts Impact on Seniors, Boomers - Wants Congress To Act
Date:3/19/2008

WASHINGTON, March 19 /PRNewswire-USNewswire/ -- Eight out of 10 Americans are concerned about access to care for seniors' and baby boomers because of government cuts to physicians caring for Medicare patients, according to a new public poll released today by the American Medical Association (AMA). On July 1, Medicare payments to physicians will be cut 10.6 percent, and over the next decade the cuts will grow to about 40 percent while medical practice costs increase 20 percent.

Seniors who rely on Medicare will be hurt by the Medicare cuts, as 60 percent of physicians say this year's cut alone will force them to limit the number of new Medicare patients they can treat. Already 30 percent of Medicare patients looking for a new primary care physician are having trouble finding one, and the cuts will make access woes much worse.

"As physicians, we are terribly concerned about how these Medicare cuts will impact our senior patients," said AMA Board Member William A. Hazel, M.D. "Seniors and boomers are concerned too, our new poll shows that 88 percent of current Medicare patients are worried about how the cuts will impact their access to health care." The first wave of baby boomers will be eligible for Medicare in three years when they turn 65.

"Military families are at risk too, as the government will also cut payments to physicians caring for military families in the Tricare program," said Dr. Hazel.

Action by the U.S. Congress is the only cure to the cuts, and nearly three-quarters of Americans polled believe Congress should stop the cuts so that physicians can continue to care for Medicare patients. The Save Medicare Act of 2008 (S. 2785), which would replace 18 months of cuts that begin in July with payment increases that better reflect medical practice costs, was recently introduced in the U.S. Senate.

"Congress has only a short window of time to act as the first Medicare cut begins in three months," said Dr. Haze
'/>"/>

SOURCE American Medical Association
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. AllMed Survey of Hospital Quality Managers Shows Much Room for Improvement in Peer Review
2. New EBRI/Commonwealth Fund Research: Enrollment in Consumer-Driven Plans Remains Low, Survey Shows
3. New Interventional Radiology Treatment Shows Hope for People With Complications from Bone Marrow, Stem Cell Transplants
4. New portrait of Earth shows land cover as never before
5. New Poll From Lake Research Shows Americans Support Allowing Physicians to Own and Operate Hospitals
6. Meditation impacts blood pressure, study shows
7. Mayo Clinic study shows Parkinsons disease drug might work in cancer patients
8. New STD Data Shows Need for Abstinence Education, Says Family Research Council
9. Avalere Study Shows Medicare Part D Helping People with Type 2 Diabetes; Warns People with Diabetes of Probability of Reaching the Donut Hole
10. Protein deficiency leads to faster fat burning in mice, study shows
11. Diabetes Ten City Challenge Collaborative Model Shows Improved Patient Health Across Key Clinical Indicators
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2
...ogs have surprised researchers by showing that the...an toddlers. The study, by Austrian researchers,... when it comes to a physical problem-solving test....en researchers first observed how several children...
...tgrave, PhD, an expert on HIV prevention at the Jo...argeted campaign of testing and counseling aimed ...e effective than the mass patient screening propos...and Prevention (CDC). Holtgraves study is the fir...
...nday against South Korea's hard-drinking culture w...d economic losses, officials said . The campaign f...re to enhance public awareness of the dangers of e...ealth and Welfare said. "South Koreans consider o...
...heimer drug in the form of a milkshake. This milks...tarved by the damages of the Alzheimer disease . I...g large scale testing against the brain destroying...d Ketasyn, is a new approach to treating dementia....
Other Medicine News:Health News:Dogs Reasoning on Par With Human Toddlers: Study 2Health News:Targeted HIV Testing An Effective Way to Screen HIV Patients 2Health News:A Milky Alternative to Alzheimer Drug 2
(Date:9/3/2008)...ber is National Vascular Disease Awareness Month, ...fusion Pharmaceuticals,LLC, a clinical-stage drug-...the treatment of unmet medical needs, announced to...e I/II clinical trial of its lead drug,candidate t...ed NCT00725881,on the clinicaltrials.gov Website, ...
(Date:9/3/2008)... Md., Sept. 3 /- Panacea Pharmaceutic...ent Number 7,413,737 covering,antibodies against h...), a,proprietary human cancer biomarker and therap...ollaboration with the Massachusetts Institute of,T...de rights to this patent,for development of human ...
(Date:9/3/2008)...Company to Discuss Phase 3 Plans with FDA, PRINCE...ics, Inc.,announced today that it successfully co... of the company,s new, innovative low-dose, once-w...rs to by its internal product,code AG-200-15. The ...t its,primary endpoint of ovulation suppression, c...
(Date:9/3/2008)...rial Reconfirms Strong Evidence Pycnogenol(R) Lowe...ect on Joints Following Cessation ...3 /- According to the Center for,Dise... type of arthritis,is on the rise. A new study pu...arch, reveals Pycnogenol(R), bark extract from the...
Breaking Medicine Technology:Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 2Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 3Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 4Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 2Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 3Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 4Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 2Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 3Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 4Stimuvax 28R 29 Phase II data highlight three year survival results for patients with non small cell lung cancer 376 1Stimuvax 28R 29 Phase II data highlight three year survival results for patients with non small cell lung cancer 376 2Stimuvax 28R 29 Phase II data highlight three year survival results for patients with non small cell lung cancer 376 3Stimuvax 28R 29 Phase II data highlight three year survival results for patients with non small cell lung cancer 376 4Cardicas C Port 28R 29 Flex A Anastomosis System Allows Surgeons to Perform Revolutionary Closed Chest Heart Bypass Surgeries 371 1Cardicas C Port 28R 29 Flex A Anastomosis System Allows Surgeons to Perform Revolutionary Closed Chest Heart Bypass Surgeries 371 2Cardicas C Port 28R 29 Flex A Anastomosis System Allows Surgeons to Perform Revolutionary Closed Chest Heart Bypass Surgeries 371 3Cardicas C Port 28R 29 Flex A Anastomosis System Allows Surgeons to Perform Revolutionary Closed Chest Heart Bypass Surgeries 371 4R P Simmons Family Foundation Pledges 242 Million for New Childrens Hospital of Pittsburgh of UPMC Campus 530 1R P Simmons Family Foundation Pledges 242 Million for New Childrens Hospital of Pittsburgh of UPMC Campus 530 2Medarex Announces Extension of Broad Antibody Development Relationship with Centocor 369 1Medarex Announces Extension of Broad Antibody Development Relationship with Centocor 369 2Medarex Announces Extension of Broad Antibody Development Relationship with Centocor 369 3
...Lymphoma Reported,Today at ASCO Annual Meeting, PH...thKline plc,announced today long-term efficacy dat...e of frontline treatment with the BEXXAR(R),Therap...momab) in,76 patients with newly diagnosed advance...gimen was found to induce durable clinical,and mol...
...e/ -- (SEND2PRESS,NEWSWIRE) -- Epeius Biotechnolog... a historic landmark in medical oncology and a,def...gene therapy.,The first clinical report of its kin...ue of the International Journal of,Oncology, Vol.3...res of tumor destruction observed in chemo-resista...
Other Medicine Technology:8-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 28-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 38-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 48-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 58-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 68-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 7News from the Battlefield of Metastatic Cancer: Epeius,Biotechnologies Draws the Sword of Targeted Gene Delivery (Rexin-G),from the Stone of Chemistry and Physics 2News from the Battlefield of Metastatic Cancer: Epeius,Biotechnologies Draws the Sword of Targeted Gene Delivery (Rexin-G),from the Stone of Chemistry and Physics 3
Tank Blotting System. Designed for Western, Northern, or Southern Blotting. Transfer up to three gels with dimensions as large as 15cm x 21.5cm. Includes and internal cooling base for temperature
... proven electrophoretic transfer apparatus incorpo...ltimate in field uniformity. Its design allows for... when coupled with a low voltage power source such...ts/cm. The result is exceptionally rapid and exact...
...lot cell, a component of Bio-Rad's modular mini el...resis Systems), provides rapid, high-quality blott...ransfers two 7.5 x 10 cm gels in just 1 hour. Cool... absorbs heat generated during transfers. The Mini...
Includes PowerPac 200 power supply. Flexibility for a Range of Parameters. Quantitative Transfers. Native Enzyme, High Intensity, or Overnight Transfers. Faster, Higher-Efficiency Transfers via Pl
Medicine Products: